Q32 Bio (QTTB) Research & Development (2017 - 2026)

Q32 Bio's Research & Development history runs 10 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• In Q1 2026, Research & Development fell 54.83% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $15.2 million (down 66.43% YoY), while the FY2025 annual figure was $19.2 million, down 60.21% from the prior year.
• Research & Development was $3.2 million for Q1 2026 at Q32 Bio, down from $3.3 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $27.1 million in Q4 2022 to a low of $3.2 million in Q1 2026.
• Historically, Research & Development has averaged $11.8 million across 5 years, with a median of $8.3 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Research & Development jumped 92.23% in 2024, then slumped 75.22% in 2025.
• A 5-year view of Research & Development shows it stood at $27.1 million in 2022, then sank by 69.28% to $8.3 million in 2023, then climbed by 26.45% to $10.5 million in 2024, then tumbled by 68.56% to $3.3 million in 2025, then slipped by 2.93% to $3.2 million in 2026.
• The last three Research & Development figures came in at $3.2 million (Q1 2026), $3.3 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.